The Endogenous Cannabinoid Anandamide and Its Synthetic Analog R(+)-Methanandamide Are Intravenously Self-Administered by Squirrel Monkeys

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Neuroscience

• Publication date

  2005-06-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1523/JNEUROSCI.0951-05.2005PMID 15944392PMCID PMC2562767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Motivational Effects of Cannabinoids and Opioids on Food Reinforcement Depend on Simultaneous Activation of Cannabinoid and Opioid Systems

  2005cited by this paper
• Self-administration of Delta(9)-tetrahydrocannabinol (THC) bydrug naive squirrel monkeys

  2004cited by this paper
• Novel Pharmacological Targets for Cannabinoids

  2004cited by this paper
• Dopamine, learning and motivation

  2004cited by this paper
• Reduced sensitivity to reward in CB1 knockout mice

  2004cited by this paper
• The endogenous cannabinoid system and the treatment of marijuana dependence.

  2004cited by this paper
• A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.

  2004cited by this paper
• The endocannabinoid system and its therapeutic exploitation

  2004cited by this paper
• The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.

  2003cited by this paper
• The Cannabinoid CB1 Antagonist N-Piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) Differentially Alters the Reinforcing Effects of Heroin under Continuous Reinforcement, Fixed Ratio, and Progressive Ratio Schedules of Drug Self-Administration in Rats

  2003cited by this paper
• Cannabinoids: reward, dependence, and underlying neurochemical mechanisms—a review of recent preclinical data

  2003cited by this paper
• The molecular logic of endocannabinoid signalling

  2003influential reference
• Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys

  2003cited by this paper
• Role of endogenous cannabinoids in synaptic signaling.

  2003influential reference
• Relative reinforcing effects of three opioids with different durations of action.

  2002cited by this paper
• Cannabinoid Addiction: Behavioral Models and Neural Correlates

  2002cited by this paper
• Anandamide receptors.

  2002cited by this paper
• Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine.

  2002cited by this paper
• Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.

  2001cited by this paper
• Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.

  2001cited by this paper
• Drug Addiction, Dysregulation of Reward, and Allostasis

  2001cited by this paper
• (R)-Methanandamide and Δ9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide

  2001cited by this paper
• Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant Rats

  2000cited by this paper
• Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys

  2000cited by this paper
• Levels, Metabolism, and Pharmacological Activity of Anandamide in CB1 Cannabinoid Receptor Knockout Mice

  2000cited by this paper
• Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.

  2000cited by this paper
• Precipitated and spontaneous withdrawal in rats tolerant to anandamide

  2000cited by this paper
• Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

  1999cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

  1999cited by this paper
• SR 141716A, a cannabinoid receptor antagonist, reverses the behavioural effects of anandamide-treated rats.

  1999cited by this paper
• Anandamide, an endogenous cannabinoid, has a very low physical dependence potential.

  1998cited by this paper
• Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.

  1998cited by this paper
• Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.

  1998cited by this paper
• Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand.

  1996cited by this paper
• The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

  1994cited by this paper
• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

  1994cited by this paper
• (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

  1994cited by this paper
• Isolation and structure of a brain constituent that binds to the cannabinoid receptor.

  1992cited by this paper
• Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey.

  1973cited by this paper

• Circulating endocannabinoids and brain anatomy: unraveling the weight loss connection through lifestyle and surgery approaches

  2025cites this paper
• Delta 9-Tetrahydrocannabinol Signaling Through Cannabinoid Receptor 1 Alters Trophoblast Differentiation

  2025cites this paper
• The State of Synthetic Cannabinoid Medications for the Treatment of Pain

  2024cites this paper
• Nutrition and addiction - are they linked in de-addictive process? A review

  2022cites this paper
• Exo- and Endo-cannabinoids in Depressive and Suicidal Behaviors

  2021cites this paper
• The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways

  2021cites this paper
• The effects of cannabis and cannabinoids on the endocrine system

  2021cites this paper
• Anandamide Influences Interleukin-1β Synthesis and IL-1 System Gene Expressions in the Ovine Hypothalamus during Endo-Toxin-Induced Inflammation

  2021cites this paper
• Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats.

  2020cites this paper
• Aerobic exercise reduces anxiety and fear ratings to threat and increases circulating endocannabinoids in women with and without PTSD.

  2020cites this paper
• Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior

  2020cites this paper
• Randomized Placebo-Controlled Clinical Trials Testing Gemfibrozil for Smoking Cessation and Melatonin for Alcohol-related Sleeping Problems

  2019cites this paper
• Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure

  2018cites this paper
• Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling

  2018cites this paper
• Loren Parsons' contribution to addiction neurobiology

  2018cites this paper
• Animal Models of Cannabis Use Disorder

  2018cites this paper
• Cannabinoid-induced Behavioral Sensitization in Adolescent Sprague-Dawley Rats

  2018cites this paper
• Brain activity of anandamide: a rewarding bliss?

  2018cites this paper
• Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors

  2017influential citation
• Synthetic Pot: Not Your Grandfather's Marijuana.

  2017cites this paper
• Role of the endocannabinoid system in vertebrates: Emphasis on the zebrafish model

  2017cites this paper
• Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology

  2017cites this paper
• N-Alkyl 4-Methylamphetamine enantiomers and the implication for potential modulation of abuse liability and enhancement of psychoactive drug targeting.

  2017cites this paper
• Cannabis: A Treasure Trove or Pandora's Box?

  2017cites this paper
• Endocannabinoid and Mood Responses to Exercise in Adults with Varying Activity Levels

  2017cites this paper
• Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg

  2016cites this paper
• Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys

  2016cites this paper
• CHAPTER 12 Cannabinoids and drugaddiction

  2016cites this paper
• Recherche des mécanismes impliqués dans la modulation de la vulnérabilité à la cocaïne par les conditions environnementales

  2016cites this paper
• Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system

  2016cites this paper
• Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats

  2016cites this paper
• Screening and Evaluation of Medications for Treating Cannabis Use Disorder

  2016cites this paper
• Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens

  2016cites this paper
• Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats

  2016cites this paper
• Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys

  2016influential citation
• Screening Medications for the Treatment of Cannabis Use Disorder.

  2016cites this paper
• Cannabinoids and drug addiction

  2015cites this paper
• Cannabinoid abuse and addiction: Clinical and preclinical findings

  2015cites this paper
• Role of the Endogenous Cannabinoid System in Nicotine Addiction: Novel Insights

  2015cites this paper
• Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policies.

  2015cites this paper
• Self-Administration of an Endogenous Cannabinoid 2-Arachidonoylglycerol in Experimentally Naïve Rats

  2015cites this paper
• Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies.

  2015cites this paper
• Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model.

  2014cites this paper
• Endocannabinoid 2-Arachidonoylglycerol Self-Administration by Sprague-Dawley Rats and Stimulation of in vivo Dopamine Transmission in the Nucleus Accumbens Shell

  2014cites this paper
• Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB1 Receptors: A Step Back into the Future

  2014cites this paper
• Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

  2014cites this paper
• Cannabinoid type-1 receptor ligands, alone or in combination with cocaine, affect vigilance-related behaviors of marmoset monkeys.

  2014cites this paper
• Regulation of brain reward by the endocannabinoid system: a critical review of behavioral studies in animals.

  2014cites this paper
• Reward, Motivation, and Addiction

  2014cites this paper
• Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

  2013cites this paper
• The role of the cannabinoid system in the neurochemistry underlying reward processes

  2013cites this paper
• The endocannabinoid system and the brain.

  2013cites this paper
• Endocannabinoid system and drug addiction: new insights from mutant mice approaches.

  2013cites this paper
• Neuroinflammation as a possible link between cannabinoids and addiction

  2013cites this paper
• Exercise-induced endocannabinoid signaling is modulated by intensity

  2013cites this paper
• Diuretic Effects of Cannabinoids

  2013cites this paper
• The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.

  2012cites this paper
• Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids

  2012cites this paper
• Paradoxical effects of the endocannabinoid uptake inhibitor VDM11 on accumbal neural encoding of reward predictive cues

  2012cites this paper
• A novel touch-sensitive apparatus for behavioral studies in unrestrained squirrel monkeys.

  2012cites this paper
• Wired to run: exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the ‘runner’s high’

  2012cites this paper
• The Endogenous Cannabinoid 2-Arachidonoylglycerol Is Intravenously Self-Administered by Squirrel Monkeys

  2011cites this paper
• Assessment of the integrative roles of the intergeniculate leaflet in circadian timing and reward pathways

  2011cites this paper
• Cannabinoids: Neurochemistry and neurobiology

  2011cites this paper
• Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

  2011cites this paper
• Reinforcing and neurochemical effects of cannabinoid CB1 receptor agonists, but not cocaine, are altered by an adenosine A2A receptor antagonist

  2011influential citation
• Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.

  2010cites this paper
• Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.

  2010cites this paper
• Animal models of cannabinoid reward

  2010influential citation
• In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.

  2010cites this paper
• THEMED ISSUE: CANNABINOIDS REVIEW Animal models of cannabinoid reward

  2010cites this paper
• Can methanandamide and gender influence pharmacokinetics of psychoactive drugs? Preclinical study on activity of cytochrome P450

  2009cites this paper
• Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Δ9-tetrahydrocannabinol

  2009influential citation
• Time-dependent induction of CREB phosphorylation in the hippocampus by the endogenous cannabinoid.

  2009cites this paper
• Drug addiction.

  2009influential citation
• Preclinical Pharmacological and Brain Bioassay Systems for CB1 Cannabinoid Receptors

  2009cites this paper
• Endocannabinoid system involvement in drug addiction,depression and neurotic disorders

  2008cites this paper
• The CB(1) cannabinoid receptor antagonist AM251 attenuates amphetamine-induced behavioural sensitization while causing monoamine changes in nucleus accumbens and hippocampus.

  2008cites this paper
• Neurobiological mechanisms of cannabinoid addiction.

  2008cites this paper
• Endocannabinoid Modulation of Spatial Memory in Aversively and Appetitively Motivated Barnes Maze Tasks

  2008cites this paper
• Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties.

  2008influential citation
• Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.

  2008cites this paper
• Blockade of THC-Seeking Behavior and Relapse in Monkeys by the Cannabinoid CB1-Receptor Antagonist Rimonabant

  2008cites this paper
• The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.

  2008cites this paper
• Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates.

  2008cites this paper
• The endocannabinoid system in brain reward processes

  2008influential citation
• Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures--a short review.

  2008cites this paper
• The Endogenous Cannabinoid Anandamide Produces δ-9-Tetrahydrocannabinol-Like Discriminative and Neurochemical Effects That Are Enhanced by Inhibition of Fatty Acid Amide Hydrolase but Not by Inhibition of Anandamide Transport

  2007cites this paper
• Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises

  2007cites this paper
• Lack of evidence for appetitive effects of Δ9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents

  2007cites this paper
• Endocannabinoid system involvement in brain reward processes related to drug abuse.

  2007influential citation
• The endogenous cannabinoid anandamide produces THC-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase ( FAAH ) but not by inhibition of anandamide transport

  2007influential citation
• An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

  2007cites this paper
• MDMA attenuates THC withdrawal syndrome in mice

  2007cites this paper
• Endocannabinoid regulation of relapse mechanisms.

  2007cites this paper
• Modulation of the endocannabinoid system: therapeutic potential against cocaine dependence.

  2007cites this paper
• Title Anxiolytic-like properties of the anandamide transport inhibitor AM 404 Permalink

  2006cites this paper
• Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats.

  2006cites this paper
• Neural mechanisms of addiction: the role of reward-related learning and memory.

  2006cites this paper
• Anxiolytic-Like Properties of the Anandamide Transport Inhibitor AM404

  2006cites this paper